bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

  Health Highlights: Dec. 16, 2016

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

HealthCare.gov Coverage Sign-Up Deadline Extended

The deadline for Americans to sign up for HealthCare.gov health insurance that would take effect Jan. 1 has been extended to 11:59 p.m. Pacific Time on Monday, Dec. 19.

The extension from the previous deadline on Thursday was due to strong interest, according to Kevin Counihan, CEO of the federal health insurance markets, the Associated Press reported.

The Obama administration wants to sign up 13.8 million people for 2017, slightly more than this year. Currently, enrollment is similar to last year, but there are fewer new clients, the news service reported.

Open enrollment ends Jan. 31.

President-elect Donald Trump and the Republican-controlled Congress have pledged to repeal and replace the 2010 health care law, often referred to as Obamacare.

-----

States Sue Generic Drug Makers Over Price Fixing

Twenty states are suing six generic drugmakers over alleged price fixing.

The lawsuit filed Thursday accuses the drugmakers of artificially inflating and manipulating prices to lessen competition for an antibiotic and a diabetes pill, CBS News/Associated Press reported.

The companies named in the lawsuit are Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma, Mayne Pharma (USA), Mylan Pharmaceuticals and Teva Pharmaceuticals.

The investigation was launched more than two years ago by the office of Connecticut Attorney General George Jepsen.

"While the principal architect of the conspiracies addressed in this lawsuit was Heritage Pharmaceuticals, we have evidence of widespread participation in illegal conspiracies across the generic drug industry," he said in a statement, CBS/AP reported.

"Ultimately, it was consumers -- and, indeed, our health care system as a whole -- who paid for these actions through artificially high prices for generic drugs," he added.

On Wednesday, federal officials charged two former Heritage executives with fixing prices. Heritage says it fired those executives in August and is fully cooperating with the Department of Justice, CBS/AP reported.

The other states involved in the lawsuit are Delaware, Florida, Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Nevada, New York, North Dakota, Ohio, Pennsylvania, Virginia and Washington.

Copyright © 2016 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=717884

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact